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Background
NASH is characterized with hepatic inflammation
and fibrosis caused by the buildup of fat and
other stimuli in the liver (two-hit theory). The
MCD diet is known to induce non-alcoholic
steatohepatitis (NASH) in a short period of time.
When MCD diet is used, more fat is trapped in
the liver. Currently no medicine is approved for
NASH treatment. Therefore, finding promising
agents to alleviate the NASH symptoms in
patients is critically needed. Cannabigerol (CBG)
is a non-psychoactive cannabinoid component
that has anti-inflammatory effects in other
studies. However, the effect of CBG on NASH is
unknown. We hypothesized that liver fibrosis
decreases with low dose of CBG administration
in MCD induced NASH mice models.

Results

Sirius Red Staining

Figure 1. low CBG shows
a decrease in Fibrosis in
both control and MCD,
high CBG does not show
a decrease in Fibrosis in
both control and
MCD. B. Shows the % of
fibrosis in each group.
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Conclusion
Fibrosis was found to be decreased in
the mice that received a low CBG dose
demonstrated by the Sirius red and αSMA staining in the control and MCD
group, but not in the mice that
received a high dose of CBG.

Aim
To assess how CBG affects liver Fibrosis in an
MCD-induced NASH mice model.

Methods

• 7–8-week-old male and female C57BL/6 mice
were fed with a MCD or matching control diet
for a total of 5 weeks.
• Mice were I.P. injected with either vehicle, low
dose (2.46 mg/kg/day), high dose (24.6
mg/kg/day) of CBG at the last two weeks.
• Liver fibrosis is evaluated with pico-Sirius red
staining, the mRNA and protein levels of
fibrosis biomarker, α-smooth muscle actin
(SMA) by qRT-PCR, and immunofluorescence
staining, respectively.

• The gene expression of α-SMA increased
in the control and MCD groups that
received high CBG treatment and
decreased in the mice that received low
CBG treatment for both control and MCD
groups.
• In the MCD group with vehicle, fibrosis is
enhanced.
• Collagen deposition decreased with low
dose of CBG, while high dose of CBG
increased collagen when compared to
MCD with vehicle.

Future Direction
Figure Two. Gene expression is present in the control and MCD
groups with high CBG, the gene expression decreased in the
control and MCD groups with low CBG. D. Shows the % of
Fibrosis in the α-SMA stain. E. Shows the gene expression in
the α-SMA.

References Han, Yuyan,; Mu, Y., Ogawa, T., & Kawada, N. (2010). Reversibility of fibrosis, inflammation, and endoplasmic reticulum stress in the liver of rats fed a methionine-choline-deficient diet. Laboratory Investigation, 90(2), 245-56.;
Oseini, A. M., & Sanyal, A. J. (2017). Therapies in non-alcoholic steatohepatitis (NASH). Liver international : official journal of the International Association for the Study of the Liver, 37 Suppl 1(Suppl 1), 97–103. https://doi.org/10.1111/liv.13302;
Tam J, Liu J, Mukhopadhyay B, Cinar R, Godlewski G, Kunos G. Endocannabinoids in liver disease. Hepatology. 2011 Jan;53(1):346-55. doi: 10.1002/hep.24077. PMID: 21254182; PMCID: PMC3073545.; Zhou, J. H., Cai, J. J., She, Z. G., & Li, H. L. (2019).
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice. World journal of gastroenterology, 25(11), 1307–1326. https://doi.org/10.3748/wjg.v25.i11.1307

• Evaluate why a low dose of CBG
decreases the expression of Fibrosis.
• Investigate what long term use of
CBG has on the liver and on Fibrosis.
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